Seeking Alpha

KaloBios Pharmaceuticals EPS of -$0.47

  • KaloBios Pharmaceuticals (KBIO): Q3 EPS of -$0.47.
  • Revenue of $9K. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector